Nuvista Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2017.
2017 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Nuvista Pharmaceuticals Private Limited

Nuvista Pharmaceuticals Private Limited, a active private limited company, was established on 20 March 2017 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304TG2017PTC115996. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.90 Cr and a paid-up capital of ₹1.90 Cr.

It upholds a compliant status. Employing 28 professional, Its leadership includes Masaram Venkataiah Goud (Director), Surya Rao Yechuri (Managing Director), Sudhakara Reddy Kalakota (Director). Past directors included Manjula Kotha, Saira Siddiqui. It holds ₹5.00 M open charges and ₹9.50 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shed No 48, Phase Ii , Ida Mallapur Mallapur, Hyderabad, Telangana, 500076.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304TG2017PTC115996

  • Registration Number

    115996

  • Incorporation Date

    20 March 2017

  • Authorized Capital

    ₹1.90 Cr

  • Paid-Up Capital

    ₹1.90 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.90 Cr
  • Paid Up Capital ₹ 1.90 Cr
  • Company Age 8 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.00 M
  • Satisfied Charges ₹ 9.50 M
  • Revenue Growth **** 4.49%
  • Profit Growth **** -72.37%
  • Ebitda **** -52.93%
  • Net Worth -1.55%
  • Total Assets **** 31.21%
Company report

Nuvista Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nuvista Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nuvista Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Masaram Venkataiah Goud Director 20 Mar 2017 Current
Surya Rao Yechuri Managing Director 20 Mar 2017 Current
Sudhakara Reddy Kalakota Director 17 Sep 2021 Current
Kallam Srikantha Reddy Director 20 Mar 2017 Current
Jakkajangreddy Director 18 May 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Mar 2019 Past
Pramod Abcsdd Director 28 Jul 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nuvista Pharmaceuticals.

Nuvista Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.49% increase. The company also saw a substantial fall in profitability, with a 72.37% decrease in profit. The company's net worth dipped by a decrease of 1.55%.

Nuvista Pharmaceuticals revenue growth over time
Nuvista Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 4.49%
*******
*******
*******
*******
Revenue from Operations
*******
 4.78%
*******
*******
*******
*******
Total Assets
*******
 31.21%
*******
*******
*******
*******
Profit or Loss
*******
 -72.37%
*******
*******
*******
*******
Net Worth
*******
 -1.55%
*******
*******
*******
*******
EBITDA
*******
 -52.93%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nuvista Pharmaceuticals?

Unlock access to Nuvista Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,000,000.00

Satisfied Charges

₹9,500,000.00

Charges Breakdown by Lending Institutions
  • Others : 0.50 Cr
Latest Charge Details
Date Lender Amount Status
15 Mar 2024 Others ₹5.00 M Open
21 Aug 2018 Others ₹9.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Nuvista Pharmaceuticals?

Nuvista Pharmaceuticals has a workforce of 28 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nuvista Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuvista Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nuvista Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Nuvista Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Nuvista Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Charges

    The activity A charge registered on 21 Aug 2018 via Charge ID 100202194 with Others was fully satisfied on 26 Mar 2024. was completed.

  • Charges

    A charge with Others amounted to Rs. 0.50 Cr with Charge ID 100889675 was registered on 15 Mar 2024. was recorded as a recent event.

  • Director Appointment

    The activity Sudhakara Reddy Kalakota was appointed as a Director was appointed as a Director on 17 Sep 2021 & has been associated with this company since 4 years 5 months . was completed.

  • Charges

    A charge with Others amounted to Rs. 0.95 Cr with Charge ID 100202194 was registered on 21 Aug 2018. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nuvista Pharmaceuticals Private Limited?

The CIN of Nuvista Pharmaceuticals Private Limited is U24304TG2017PTC115996.

Where is Nuvista Pharmaceuticals Private Limited headquartered?

Nuvista Pharmaceuticals Private Limited is headquartered at Shed No 48, Phase Ii , Ida Mallapur Mallapur, Hyderabad, Telangana, 500076.

When was Nuvista Pharmaceuticals Private Limited incorporated?

Nuvista Pharmaceuticals Private Limited was incorporated on 20 March 2017.

Who are the current directors of Nuvista Pharmaceuticals Private Limited?

The current directors of Nuvista Pharmaceuticals Private Limited are

What is the primary industry of Nuvista Pharmaceuticals Private Limited?

The primary industry of Nuvista Pharmaceuticals Private Limited is Manufacturing.

Is Nuvista Pharmaceuticals Private Limited a listed company?

Nuvista Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Nuvista Pharmaceuticals Private Limited?

The authorized capital of Nuvista Pharmaceuticals Private Limited is ₹1.90 Cr, and the paid-up capital is ₹1.90 Cr.

What is the compliance status of Nuvista Pharmaceuticals Private Limited?

The compliance status of Nuvista Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available